Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs Capricor Therapeutics, Inc. (CAPR)

Assembly Biosciences, Inc. and Capricor Therapeutics, Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. is the larger, with a market value of $479.1M against $405.6M — 1.2× the size. Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against −11.6%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −0.06%) and the lower return on invested capital (−1,019.7% vs 0.00%). Across the 16 metrics below, Assembly Biosciences, Inc. leads on 10 and Capricor Therapeutics, Inc. on 6.

Valuation

Metric ASMB CAPR Biotechnology median
P/E n/m n/m 10.64
P/S 5.04 21.17 9.59
P/B 1.23 1.92 2.15
Price to free cash flow n/m 3.60 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 0.76 11.13 9.45
Earnings yield (0.80%) (30.10%) (34.69%)
Free cash flow yield (10.23%) 27.76% (24.02%)

Profitability

Metric ASMB CAPR Biotechnology median
Gross margin 100.00% 100.00% 65.59%
Operating margin (11.75%) 0.00% 0.00%
Net margin (0.06%) 0.00% 0.00%
Free cash flow margin (51.53%) 0.00% 0.00%
Return on equity (0.03%) (73.70%) (51.96%)
Return on assets (0.02%) (51.53%) (46.06%)
Return on invested capital 0.00% (1,019.73%) 0.00%

Growth

Metric ASMB CAPR Biotechnology median
Revenue growth (TTM) 125.12% (11.55%) 4.59%
EPS growth (last fiscal year) 91.78% (96.52%) 29.88%
Revenue growth, 5-year CAGR 35.27% 85.83% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB CAPR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 7.35 4.86
Net debt to EBITDA 17.31 2.99 1.01

Dividend

Metric ASMB CAPR Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ASMB CAPR Biotechnology median
Market cap 405.59m 479.07m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack